This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Oral Cancer Global Clinical Trials Review, H2, 2012

Oral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2012* 52

Oral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2012* 53

Oral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 54

Oral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Mississippi Medical Center, 2012* 55

Oral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by VCU Massey Cancer Center, 2012* 56

List of Figures

List of Figures

Oral Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7

Oral Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8

Oral Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9

Oral Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 10

Oral Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11

Oral Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12

Oral Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 13

Oral Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 14

Oral Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 15

Oral Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 16

Oral Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17

Oral Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 18

Oral Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19

Oral Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20

Oral Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21

4 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs